Patients with N3 head and neck squamous cell carcinoma exhibit 5-year overall survival rates of approximately 30% regardless of treatment modality. Planned neck dissection does not improve regional control in patients undergoing definitive chemoradiotherapy. p16-positive patients represent a favorable cohort. Distant failure comprises the major failure pattern and should be the focus of future studies in improving the outcome of this patient cohort.
Keyphrases
- patients undergoing
- end stage renal disease
- lymph node
- ejection fraction
- chronic kidney disease
- case report
- newly diagnosed
- locally advanced
- prognostic factors
- peritoneal dialysis
- neoadjuvant chemotherapy
- type diabetes
- current status
- patient reported outcomes
- metabolic syndrome
- free survival
- patient reported
- case control